Cytomos

To add a bio or update company history, please click update information.

News from Cytomos

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

19 Nov 2024

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

Cytomos builds scalable cell analysis technology that measures intrinsic cellular properties in real time, helping biopharma companies accelerate drug discovery and manufacturing decisions.

Cytomos

Life Sciences
Edinburgh, United Kingdom
£5m
cytomos.com
Update Information

More venture news

ViaNautis
9 Sept 2026
ViaNautis secures investment from SCI Ventures to deliver non-viral genetic medicines to cells at spinal cord injury sites
EquityLife Sciences
Pharosyn
2 Sept 2026
Pharosyn secures £2.2m in funding led by Moonfire to improve commercial decision-making inside pharma companies
EquityLife Sciences
CN Bio
12 Aug 2026
CN Bio secures a £180k Innovate UK grant to develop organ-on-a-chip system for drug behaviour predictions
GrantLife Sciences

Cytomos

News from Cytomos

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

More venture news

ViaNautis secures investment from SCI Ventures to deliver non-viral genetic medicines to cells at spinal cord injury sites

Pharosyn secures £2.2m in funding led by Moonfire to improve commercial decision-making inside pharma companies

CN Bio secures a £180k Innovate UK grant to develop organ-on-a-chip system for drug behaviour predictions